Jim Simons's position in Cue Biopharma is currently worth $291k. That's 0.00% of their equity portfolio (2581st largest holding). The first Cue Biopharma trade was made in Q4 2019. Since then Jim Simons bought shares fourteen more times and sold shares on eight occasions. The investor's estimated purchase price is $348k, resulting in a loss of 16%.